Platt Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$633K Buy
528
+31
+6% +$31.7K 0.51% 28
2026
Q1
$457K Hold
497
0.45% 33
2025
Q4
$533K Buy
+497
New +$475K 0.53% 28

Other funds holding LLY

Platt Wealth Management's LLY Position: Q2 2026 in Review

Platt Wealth Management increased its Eli Lilly (LLY) stake by 6.2% in Q2 2026, buying an estimated $31.7K and bringing the position to 528 shares worth $633K. The position accounts for 0.51% of the portfolio, ranked #28.

Platt Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Platt Wealth Management held 528 shares of Eli Lilly worth $633K as of Q2 2026.
  • Platt Wealth Management bought 31 Eli Lilly shares in Q2 2026, an estimated $31.7K.
  • Eli Lilly made up 0.51% of Platt Wealth Management's portfolio in Q2 2026, its #28 holding.
  • Platt Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Platt Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.